- Home
- MOGU vs AYTU Comparison
MOGU vs AYTU Comparison
Compare MOGU & AYTU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOGU
- AYTU
- Stock Information
- Founded
- MOGU 2011
- AYTU N/A
- Country
- MOGU China
- AYTU United States
- Employees
- MOGU N/A
- AYTU N/A
- Industry
- MOGU Business Services
- AYTU Biotechnology: Pharmaceutical Preparations
- Sector
- MOGU Consumer Discretionary
- AYTU Health Care
- Exchange
- MOGU Nasdaq
- AYTU Nasdaq
- Market Cap
- MOGU 19.8M
- AYTU 19.7M
- IPO Year
- MOGU 2018
- AYTU N/A
- Fundamental
- Price
- MOGU $4.48
- AYTU $2.37
- Analyst Decision
- MOGU
- AYTU Strong Buy
- Analyst Count
- MOGU 0
- AYTU 2
- Target Price
- MOGU N/A
- AYTU $10.00
- AVG Volume (30 Days)
- MOGU 3.7M
- AYTU 100.5K
- Earning Date
- MOGU 07-21-2025
- AYTU 11-12-2025
- Dividend Yield
- MOGU N/A
- AYTU N/A
- EPS Growth
- MOGU N/A
- AYTU N/A
- EPS
- MOGU N/A
- AYTU N/A
- Revenue
- MOGU $19,462,964.00
- AYTU $81,659,000.00
- Revenue This Year
- MOGU N/A
- AYTU N/A
- Revenue Next Year
- MOGU N/A
- AYTU $2.00
- P/E Ratio
- MOGU N/A
- AYTU N/A
- Revenue Growth
- MOGU N/A
- AYTU 0.41
- 52 Week Low
- MOGU $1.83
- AYTU $0.95
- 52 Week High
- MOGU $8.10
- AYTU $2.85
- Technical
- Relative Strength Index (RSI)
- MOGU 69.30
- AYTU 55.75
- Support Level
- MOGU $4.10
- AYTU $2.21
- Resistance Level
- MOGU $5.50
- AYTU $2.58
- Average True Range (ATR)
- MOGU 0.60
- AYTU 0.13
- MACD
- MOGU 0.21
- AYTU 0.01
- Stochastic Oscillator
- MOGU 39.53
- AYTU 48.78
About MOGU MOGU Inc.
MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.
About AYTU Aytu BioPharma Inc.
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.